These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12911075)

  • 21. [Meloxicam--the balance of efficacy and safety].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):85-6. PubMed ID: 19024285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
    Housholder GT; Chan JT
    J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tolerance to celecoxib and meloxicam in patients with intolerance to nonsteroidal anti-inflammatory drugs].
    Vázquez-Cortés S; Vázquez-Fuertes L; Rodríguez-Alvarez M; Reig Rincón de Arellano I; Martínez-Cócera C
    An Med Interna; 2008 Apr; 25(4):163-7. PubMed ID: 18604331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors.
    Hilário MO; Terreri MT; Len CA
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S206-12. PubMed ID: 17136297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meloxicam: influence on arachidonic acid metabolism. Part II. In vivo findings.
    Engelhardt G; Bögel R; Schnitzler C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):29-38. PubMed ID: 8534265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Valdecoxib (Bextra)].
    Scheen AJ; Malaise M
    Rev Med Liege; 2004 Apr; 59(4):251-4. PubMed ID: 15182039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain.
    Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do selective cyclo-oxygenase inhibitors eliminate the adverse events associated with nonsteroidal anti-inflammatory drug therapy?
    Devière J
    Eur J Gastroenterol Hepatol; 2002 Sep; 14 Suppl 1():S29-33. PubMed ID: 12570027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of preemptive acetaminophen, ibuprofen, and meloxicam on pain after separator placement: a randomized clinical trial.
    Zarif Najafi H; Oshagh M; Salehi P; Babanouri N; Torkan S
    Prog Orthod; 2015; 16():34. PubMed ID: 26467790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs.
    Watson DJ; Bolognese JA; Yu C; Krupa D; Curtis S
    Curr Med Res Opin; 2004 Dec; 20(12):1899-908. PubMed ID: 15701208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib.
    Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):34-8. PubMed ID: 15702813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance.
    Prieto A; De Barrio M; Martín E; Fernández-Bohórquez M; de Castro FJ; Ruiz FJ; Herrero T; Tornero P; Rubio M
    J Allergy Clin Immunol; 2007 Apr; 119(4):960-4. PubMed ID: 17292954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam.
    Curtiss FR
    J Manag Care Pharm; 2006 Apr; 12(3):265-8. PubMed ID: 16623613
    [No Abstract]   [Full Text] [Related]  

  • 34. Cox 2: the next stage in the NSAID story.
    Averns H
    Practitioner; 1996 Sep; 240(1566):532-4. PubMed ID: 8984462
    [No Abstract]   [Full Text] [Related]  

  • 35. Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.
    Laine L; Curtis SP; Langman M; Jensen DM; Cryer B; Kaur A; Cannon CP
    Gastroenterology; 2008 Nov; 135(5):1517-25. PubMed ID: 18823986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial design and patient demographics of the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) study program: cardiovascular outcomes with etoricoxib versus diclofenac in patients with osteoarthritis and rheumatoid arthritis.
    Cannon CP; Curtis SP; Bolognese JA; Laine L;
    Am Heart J; 2006 Aug; 152(2):237-45. PubMed ID: 16875903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meloxicam: influence on arachidonic acid metabolism. Part 1. In vitro findings.
    Engelhardt G; Bögel R; Schnitzer C; Utzmann R
    Biochem Pharmacol; 1996 Jan; 51(1):21-8. PubMed ID: 8534264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of nimesulide versus meloxicam in the control of pain, swelling and trismus following extraction of impacted lower third molar [Int. J. Oral Maxillofac. Surg. 39 (2010) 580-584].
    Loh JS; Ong CW
    Int J Oral Maxillofac Surg; 2011 Jan; 40(1):125. PubMed ID: 20875946
    [No Abstract]   [Full Text] [Related]  

  • 39. Meloxicam (Mobic) for osteoarthritis.
    Med Lett Drugs Ther; 2000 May; 42(1079):47-8. PubMed ID: 10859731
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac.
    Dreiser RL; Le Parc JM; Vélicitat P; Lleu PL
    Inflamm Res; 2001 Mar; 50 Suppl 1():S17-23. PubMed ID: 11339516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.